Sphingosine-1-phosphate stimulates smooth muscle cell migration through Gαi- and PI3-kinase-dependent P38MAPK activation

Journal of Surgical Research

Volumn 113, Issue 1, 2003, Pages 32-41

  Fegley, Allison J ^a   Tanski, William J ^a   Roztocil, Elisa ^a   Davies, Mark G ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

G protein signaling; Migration; P38 MAP kinase; PI3 kinase; Signal transduction; Smooth muscle cells; Sphingosine 1 phosphate

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR ALPHA I; MAPKAP KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P 38; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN P13; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVATION; IMMUNOPRECIPITATION; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 0042235069     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00120-3     Document Type: Article

References (37)

1. Davies M.G., Hagen P.-O. Pathobiology of intimal hyperplasia. British J. Surg. 81:1994;1254.
2. Yatomi Y., Igarashi Y., Yang L., Hisano N., Qi R., Asazuma N., Satoh K., Ozaki Y., Kume S. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. 121:1997;969.
3. Goetzl E.J., An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12:1998;1589.
4. English D., Garcia J.G., Brindley D.N. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 49:2001;588.
5. Liu F., Verin A.D., Wang P., Day R., Wersto R.P., Chrest F.J., English D.K., Garcia J.G. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of the G(ialpha2)-linked Rho kinase activity. Am. J. Respir. Cell Molec. Biol. 24:2001;711.
6. Paik J.H., Chae S., Lee M.J., Thangada S., Hla T. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of Edg-1 and -3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J. Biol. Chem. 276:2001;11830.
7. Yatomi Y., Ohmori T., Rile G., Kazama F., Okamoto H., Sano T., Satoh K., Kume S., Tigyi G., Igarashi Y., Ozaki Y. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood. 96:2000;3431.
8. English K., Welch Z., Kovala A.T., Harvey K., Volpert O.V., Brindley D.N., Garcia J.G. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 14:2000;2255.
9. Okamoto H., Yatomi Y., Ohmori T., Satoh K., Matsumoto Y., Ozaki Y. Sphingosine 1-phosphate stimulates G(i)- and Rho-mediated vascular endothelial cell spreading and migration. Thromb. Res. 99:2000;259.
10. Kimura T., Watanabe Y., Sato K., Kon J., Tomura H., Tamama K., Kuwahara A., Kanda T., Kobayashi I., Ohta H., Ui M., Okajima F. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and -3. Biochem. J. 348:2000;71.
11. Wang F. Van Brocklyn, J. R., Hobson, J. P., Movafagh, S., Zukowska-Grojec, Z., Milstien, S., and Spiegel, S. Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem. 274:1999;35343.
12. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., Rosenfeldt H.M., Nava V.E., Chae S.S., Lee M.J., Liu C.H., Hla T., Spiegel S., Proia R.L. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106:2000;951.
13. Ono K., Han J. The p38 signal transduction pathway activation and function. Cell. Signalling. 12:2000;1.
14. Kozawa O., Tanabe K., Ito H., Matsuno H., Niwa M., Kato K., Uematsu T. Sphingosine 1-phosphate regulates heat shock protein 27 induction by a p38 MAP kinase-dependent mechanism in aortic smooth muscle cells. Exp. Cell Res. 250:1999;376.
15. Tanski W., Roztocil E., Davies M. Sphingosine-1-phosphate induces Gαi-coupled, PI3-K/ras-dependent smooth muscle cell migration. J. Surg. Res. 108:2002;98.
16. Ui M., Katada T., Murayama T., Kurose H. Selective blockage by islet-activating protein, pertussis toxin, of negative signal transduction from receptors to adenylate cyclase. Adv. Exp. Med. Biol. 175:1984;1.
17. 0 are resistant to pertussis toxin-catalyzed ADP-ribosylation. FEBS Lett. 441:1998;67.
18. Nakanishi S., Kakita S., Takahashi I., Kawahara K., Tsukuda E., Sano T., Yamada K., Yoshida M., Kase H., Matsuda Y. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem. 267:1992;2157.
19. Powis G., Bonjouklian R., Berggren M., Gallegos A., Abraham R., Ashendel C., Zalkow L., Matter W., Dodge J., Grindey G. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54:1994;2419.
20. Duan C., Bauchat J.R., Hsieh T. Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration. Circ. Res. 86:2000;15.
21. Vlahos C., Matter W., Hui K., Brown R. A specific inhibitor of phosphatidylinositol 3 kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241.
22. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489.
23. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229.
24. Davies S., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95.
25. Kalmes A., Deou J., Clowes A., Daum G. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580. FEBS Lett. 444:1999;71.
26. Eguchi S., Numaguchi K., Iwasaki H., Matsumoto T., Yamakawa T., Utsunomiya H., Motley E., Kawakatsu H., Owada K.M., Hirata Y., Marumo F., Inagami T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273:1998;8890.
27. Wu J., Cunnick J. Trans-regulation of epidermal growth factor receptor by lysophosphatidic acid and G protein-coupled receptors. Biochim. Biophys. Acta. 1582:2002;100.
28. Kalmes A., Vesti B., Daum G., Abraham J., Clowes A. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ. Res. 87:2000;92.
29. Wang L., Hayashi H., Kishi K., Huang L., Hagi A., Tamaoka K., Hawkins P., Ebina Y. Gi-mediated translocation of GLUT4 is independent of p85/p110α and p110γ phosphoinositide 3-kinases but might involve the activation of Akt kinase. Biochem. J. 345:2000;543.
30. Gorin Y., Kim N., Feliers D., Bhandari B., Choudhury G., Abboud H. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. FASEB J. 15:2001;1909.
31. Kluk M., Hla T. Role of the sphingosine-1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ. Res. 89:2001;496.
32. Rosenfeldt H., Hobson J., Milstien S., Spiegel S. The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility. Biochem. Soc. Trans. 29:2001;836.
33. Takuwa Y., Okamoto H., Takuwa N., Gonda K., Sugimoto N., Sakurada S. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator. Mol. Cell. Biol. 177:2001;3.
34. Yasuji R., Takuwa N., Sugimoto N., Sakurada S., Usui S., Okamoto H., Matsui O., Takuwa Y. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular rac activity and cell migration in vascular smooth muscle cells. Circ. Res. 90:2002;325.
35. Osada M., Yatomi Y., Ohmori T., Ikeda H., Ozaki Y. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem. Biophys. Res. Commun. 299:2002;483.
36. Matsumoto T., Yokote K., Tamura K., Takemoto M., Ueno H., Saito Y., Mori S. Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. J. Biol. Chem. 274:1999;13954.
37. Gerthoffer W.T., Gunst S.J. Invited review focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle . J. Appl. Physiol. 91:2001;963.